Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Catalent has unveiled plans to invest in a European center of excellence for clinical biologics formulation development and drug product fill/finish services at its facility in Limoges, France.

Catalent Invests Millions to Create European Clinical Manufacturing Center of Excellence

Pharmaceutical Technology spoke with Geoff Parker, co-founder of Scimcon about the impact COVID-19 is having on their business.

The Impact of COVID-19 on Outsourcing

The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.

Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria

Lonza is making additional investments in its global particle engineering network for expanded capacity and specialized capabilities.

Lonza Announces Additional Investments in Global Particle Engineering Services

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.

Demand for Custom Dosage Forms Fuels Innovation

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.

Contractors Balance Increased Demand During COVID-19

Cambrex has invested in an expansion of its flexible manufacturing facility in Sweden, which will increase the company’s flexible drug substance manufacturing capacity.

Cambrex Expands Flexible Manufacturing Capacity in Sweden

Find connections to suppliers of the materials, equipment, and services you need to develop, manufacture, and distribute crucial therapies, treatments, and vaccines in the 2020 Pharmaceutical Technology Buyers' Guide.

Pharmaceutical Technology 2020 Buyers' Guide

The company now offers its CONFIDENCE virus clearance services to support validation of viral clearance processes.